SABSW icon

SAB Biotherapeutics, Inc. Warrant

9 hedge funds and large institutions have $66.3K invested in SAB Biotherapeutics, Inc. Warrant in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
Holders Change %
0%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
3
Closed
2
Calls
$5K
Puts
Net Calls
+$5K
Net Calls Change
-$17K
Name Holding Trade Value Shares
Change
Shares
Change %
LP
1
LMR Partners
United Kingdom
$40.6K +$40.6K +539,588 New
Morgan Stanley
2
Morgan Stanley
New York
$11K
YCM
3
Yakira Capital Management
Connecticut
$7.02K -$1.15K -15,255 -14%
HWM
4
HB Wealth Management
Georgia
$3.87K -$20.1K -259,999 -84%
Walleye Trading
5
Walleye Trading
New York
$2.92K +$1.75K +23,258 +150%
WAM
6
Wolverine Asset Management
Illinois
$651 -$516 -6,864 -44%
UBS Group
7
UBS Group
Switzerland
$122 +$122 +1,633 New
NA
8
NewEdge Advisors
Louisiana
$80
TRCT
9
Tower Research Capital (TRC)
New York
$4
Walleye Capital
10
Walleye Capital
New York
-$837 -23,258 Closed
CS
11
Clear Street
New York
-$7 -200 Closed